GSK PLC Sponsored ADR (GSK)
(Delayed Data from NYSE)
$37.56 USD
+0.41 (1.10%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $37.55 -0.01 (-0.03%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth F Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, GSK PLC Sponsored ADR has a market cap of $75.84B, which represents its share price of $37.15 multiplied by its outstanding shares number of 2.04B. As a large-cap company, GSK's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
GSK 37.56 +0.41(1.10%)
Will GSK be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GSK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GSK
Company News for Jul 31, 2025
GSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise
GSK: What are Zacks experts saying now?
Zacks Private Portfolio Services
GSK (GSK) Q2 Earnings and Revenues Beat Estimates
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth
Other News for GSK
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Experts helping vaccine advisors are reportedly ousted at CDC
Trump Trade: Trump signs executive order raising tariff on Canada to 35%
European pharmaceutical stocks slip after Trump pushes for lower drug prices